11:01 AM EDT, 04/26/2024 (MT Newswires) -- (Updates to include recent stock movement in the headline and first paragraph.)

ResMed ( RMD ) shares rose by more than 17% in recent Friday trading after the company reported fiscal Q3 non-GAAP earnings of $2.13 per diluted share, up from $1.68 a year earlier.

Analysts surveyed by Capital IQ expected $1.91.

Revenue for the quarter ended March 31 was $1.20 billion, up from $1.12 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.17 billion.

The board maintained the quarterly dividend at $0.48 per share, payable on June 13 to shareholders of record on May 9.

Price: 215.68, Change: +32.26, Percent Change: +17.59